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ABSTRACT
The effect of prenatal zinc supplementation on birthweight is controversial as randomized controlled trials 
(RCTs) report conflicting conclusions. A systematic review which includes meta-analysis was done on 17 RCTs 
conducted worldwide since 1984 to assess the effect of prenatal zinc supplementation on birthweight. The 
studies were identified through web-based search. Heterogeneity among studies was assessed using Cochrane 
Q test statistic. Effect-size was measured based on standardized mean difference. Pooled effect-size was 
computed using a variant of random effect model. Thirteen of the 17 RCTs found no association,   
three reported positive association, and one reported negative association. Based on fixed and random ef-
fect models, the pooled effect-sizes were 0.0268 [95% confidence interval (CI) 0.0764, -0.0229) and 0.0712 
(95% CI 0.1619, -0.0194) respectively. The effect-size estimate remains insignificant after stratification was 
made based on the dose of supplementation (optimal vs high dose), type of study (community vs institu-
tion-based), and type of source country (developed vs developing). The meta-analysis did not witness any 
association between birthweight and prenatal zinc supplementation. 
Key words: Birthweight; Medical research; Meta-analysis; Impact studies; Randomized control trails; Sys-
tematic review; Zinc supplementation
INTRODUCTION
Zinc is one of the essential trace elements and a 
member of the major micronutrients which have 
attained prominence in human health and nutri-
tion (1). It is required for many biological func-
tions, including DNA synthesis, cell division, gene 
expression, and stabilization of molecular struc-
tures. It is also vital for the activity of more than 
300 enzymes participating in the metabolism of 
macronutrients, micronutrients, and nucleic acids 
(2,3). Since its importance for human physiology 
was identified in 1963, many studies witnessed its 
crucial importance for immune function, linear 
growth and gain in weight, and neuropsychologi-
cal and cognitive functions of human beings. Its 
involvement in such diverse and fundamental ac-
tivities probably accounts for its essentiality for all 
forms of life (3).
Poor maternal zinc status is associated with adverse 
pregnancy outcomes as zinc is assumed to be es-
sential for normal foetal growth and development 
(4). Animal experiments indicate that severe prena-
tal zinc deficiency is associated with spontaneous 
abortion and congenital malformations (5) where-
as milder forms are attributed to low birthweight 
(LBW), intrauterine growth retardation (IUGR), 
and preterm delivery (6). Difficult and prolonged 
labour, haemorrhage, uterine dystocia, and placen-
tal abruption have also been documented in female 
rats fed zinc-deficient diets throughout pregnancy 
(7). The poor pregnancy outcomes in women with 
acrodermatitis enteropathica are also consistent 
with effects observed in zinc-deficient pregnant 
animals (8). However, studies that attempted to 
evaluate the effect of prenatal zinc status on mater-
nal health and pregnancy outcomes in apparently 
healthy individuals yielded conflicting conclusions 
(9). 
As to the effect of prenatal zinc supplementation 
on anthropometric indicators is concerned, of 
more than 20 RCTs conducted so far, few reported 
positive association between zinc supplementation 
and anthropometric measurements. According to 
a study in India, birthweight of infants born to 
women in the placebo group averaged only 2.6 kg Gebreselassie SG and Gashe FE 
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(10). Infants born to zinc-supplemented mothers 
were 0.3-0.8 kg heavier, depending on the length 
of time supplemental zinc was provided for. If zinc 
supplementation was initiated in the first trimester, 
the effect on birthweight would be greater than if it 
was initiated in the third trimester (10). A study in 
the USA among disadvantaged African-American 
women reported that supplemented zinc increased 
birthweight by 126 g and increased head-circum-
ference of infant by 0.4 cm (11). Another study in 
the USA (12) and a study in Chile (13) reported 
that zinc supplementation enhanced birthweight 
significantly—approximately by 150 and 69 g re-
spectively. A study in Iran found significantly high-
er head-circumference of newborns in the supple-
mented group than in the control group (35.0 cm 
vs 33.7 cm) but no increments in birthweight (14). 
However, the remaining RCTs  failed to witness any 
association between anthropometric indicators and 
prenatal zinc supplementation (15-25). 
The objective of this systemic review and meta-
analysis was to examine the effect of prenatal zinc 
supplementation on birthweight. A similar meta-
analysis was published in 2009 by the Cochrane 
Collaboration Group (26). However, this analysis 
has included four more additional studies and pro-
vided the results based on both fixed and random 
effect models. 
MATERIALS AND METHODS
Study design 
This is a systematic review which includes a meta-
analysis.
Inclusion and exclusion criteria
To assure the quality of analysis, only RCTs were 
included in the analysis. Articles written in only 
English language were considered. The exclusion 
criteria were set based on  multiple criteria, includ-
ing low dose of supplementation (less than 15 mg/
day), unavailability of vital information in the arti-
cles (mean and standard deviation of birthweight 
in intervention and control arms, percentage of 
LBW babies in both arms) and low level of compli-
ance (<70%) for the supplement.
Search strategy and evaluation of studies
Studies were mainly identified through web-based 
descendent (identifying key literature and look on-
line the other studies which cite them) and ances-
tor (look into the references of a key article) search 
techniques. The study did not involve any manual 
search of articles or contacts with authors. The elec-
tronic search was performed within the Cochrane 
Library and MEDLINE databases. Further studies 
were identified using the Google Scholar search 
engine. Key combination search terms were “zinc 
supplementation and birthweight” and “zinc sup-
plementation and birth outcomes”. Literature writ-
ten in only English language were considered, and 
no limit was made on date of publication of the 
articles. 
Initially, 21 (20 published and 1 PhD dissertation) 
articles and abstracts based on RCTs were located. 
The principal investigators reviewed all of them 
using the predefined inclusion criteria. They also 
checked quality of the studies in terms of reason-
able level of compliance for the supplementation 
(>70% compliance), follow-up (<30% loss to fol-
low- up), and assuring the comparability of the in-
tervention and control groups based on key vari-
ables (maternal age, educational status, maternal 
anthropometric indicators, gestational age, parity, 
etc.). Disagreements were solved by repeated evalu-
ations and discussions. 
Three of the 21 RCTs, conducted in Germany (27), 
USA (28) and Denmark (29), were excluded as vital 
information, such as mean and standard deviation 
of birthweight in intervention and control arms 
and proportion of LBW babies in both arms, could 
not be extracted from the articles and abstracts. A 
study in South Africa was also excluded since it 
used very low dose (4.3-12.9 mg/day) of zinc sup-
plementation (30). Hence, the analysis was done   
with the remaining 17 studies.  
From each of the studies included, information on 
total number of zinc-supplemented and control 
children, number of LBW babies (<2,500 g), mean 
birthweight and standard deviation (SD) for both 
arms, nature of the population, and dose and dura-
tion of supplementation were extracted. 
Analysis of data 
The description of original studies was made using 
frequency and forest plot. Heterogeneity among 
studies was statistically assessed using Cochrane Q 
test statistic. The test statistic indicated random hete- 
rogeneity among studies (p=0.09). Hence, random 
effect model was used in the analysis. Among stud-
ies, variation was assessed using DerSimonian and 
Laird’s (DL’s) estimator. To control the effect of dose 
of supplementation (optimal or high dose), type of 
the study (community or institution-based), and 
type of source country (developed or developing), 
stratified analysis was made. We analyzed data us- 
ing Metaeasy add-in for the MS Excel software (ver-
sion 1.0). As relatively fewer articles were included Gebreselassie SG and Gashe FE  Prenatal zinc supplementation and birthweight
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in the analysis, Funnel plot was not used for assess-
ing publication bias.
The strength of association between zinc supple-
mentation and birthweight was assessed using 
effect-size which measures the strength or magni-
tude of difference between two sets of data (in this 
case treatment groups). It is the difference between 
the mean values of the two groups, divided by the 
standard deviation. The larger the effect-size, the 
greater is the difference or impact of an interven-
tion. Cohen proposed operational definitions of 
0.2, 0.5, and 0.8 as small, medium, and large effect-
sizes respectively (31). 
RESULTS 
Description of original studies
Four studies from the USA, three from the UK, six 
from Asian countries, three from Latin American 
countries, and only one from Africa were includ-
ed in the analysis. In total, these studies involved 
6,209 pregnant women in intervention and con-
trol arms. The sample-size of the studies ranged 
from 1,075 in Nepal (32) to 52 in the UK (18). With 
the exception of six community-based studies, all 
were health institution-based. All the studies ran-
domized the study subjects into intervention and 
control groups around the mid-point of the second 
trimester (16-20 weeks). The dose of the supple- 
ment in 12 studies was 15-25 mg/day. However, 
in the remaining five studies, a higher dose (25-62 
mg/day) of supplementation was used. All the stud-
ies were published in the last 25 years (1984-2009). 
The basic information of each specific study is pre-
sented in Table 1. 
Pooled effect-size
The effect-size estimate of the specific studies sho- 
wed that the majority (n=13) of the studies found 
no association between zinc supplementation and 
birthweight. Three studies reported positive as-
sociation while one study reported negative asso-
ciation. Based on fixed and random effect model 
assumptions, the mean (pooled) effect-sizes were 
0.0268 (95% CI 0.0764, -0.0229) and 0.0712 (95% 
CI 0.1619, -0.0194) respectively. In both the cases, 
the meta-analysis showed no significant associa-
tion between birthweight and zinc supplementa-
tion. The specific and pooled effect-sizes are pre-
sented in the figure. 
To control the possible effect of confounders, strati-
fication was made based on type of country (de-
veloped or developing), dose of supplementation 
(optimal or high dose), and type of study (health 
institution-based or community-based). The classi-
fication into developed or developing country was 
made according to the World Bank cut-off point of 
gross national income per capita of US$ 3,945 (33). 
The mean effect-sizes, based on the fixed and ran-
dom effect models for the respective categories, are 
summarized in Table 2.
In all the categories, the Q test statistic was 0.5-0.05 
and, as such, the random effect model was taken 
as the appropriate estimator of pooled effect-size. 
The stratification indicated that prenatal zinc sup-
plementation was not associated with birthweight, 
irrespective of dose, type of study, and country.  
DISCUSSION
Another meta-analysis of 14 RCTs conducted by 
Cochrane group also failed to show any association 
between prenatal zinc supplementation and birth-
weight (26). According to this study, the pooled dif-
ference in the mean birthweight between the zinc 
supplemented and the control group was -10.59 g 
(95% CI -36.71, 15.54). Of 10 studies conducted 
in populations with low serum zinc or low dietary 
zinc intake, the pooled difference in the mean 
birthweight between the zinc-supplemented and 
the control group was -11.42 g (95% CI  -38.82, to 
15.98) (26). Of three studies conducted in popula-
tion with normal zinc status or adequate dietary 
zinc intake, the pooled difference in the mean 
birthweight between the zinc-supplemented and 
the control group was-2.32 g (95% CI -88.94, to 
84.30). In both the strata, zinc supplementation 
had no association with birthweight (26). 
However, the finding of the two meta-analyses was 
not consistent to what is documented by many ob-
servational studies. In Japan, Higashi A et al. have 
demonstrated that maternal serum zinc level in the 
second trimester was not related to birthweight of 
infants (34); however, zinc status in the third tri-
mester was an important determinant. A case-con-
trol study in Tanzania reported that mothers with 
low zinc levels were 2.6 times more at risk of having 
LBW babies compared to those with normal zinc 
levels, and newborns with low zinc levels were 2.8 
times more at risk of being born with low weight 
(35). A study in the USA also found that, among 
both white and black mothers, serum zinc concen-
tration was significantly related to birthweight after 
various independent determinants of birthweight 
were controlled (36). A similar association was also 
documented by studies in Turkey (37), India (38), 
and China (39). 
The discrepancy between the conclusion of this 
analysis and the findings of many observational Gebreselassie SG and Gashe FE 
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Table 2.  Mean effect-size in different categories of studies: 17 randomized controlled trials on the                               
association between prenatal zinc supplementation and birthweight, 1984-2009  
Stratifying variable
Total sample-size 
of studies
Effect-size with 
95% CI
(fixed effect model)
Effect-size with 
95% CI
(random effect model)
Type of country 
Developed  1,863 0.107 (0.197, -0.017) 0.107 (0.199, -0.016)
Developing  4,345 -0.008 (0.051, -0.068) 0.057 (0.183, -0.070)
Type of study 
Community-based 3,476 0.101 ( 0.174, 0.026) 0.129 (0.267, -0.010)
Health institution-based 2,732 -0.031 ( 0.041, -0.103) 0.075 (0.268, -0.118)
Dose of supplementation 
15-25 mg/day 4,869 0.016 (0.072, -0.040) 0.040 (0.123, -0.043)
26-62 mg/day 1,339 0.067 (0.175, -0.041) 0.169 (0.457, -0.119)
CI=Confidence interval
studies cannot be explained by non-compliance to 
zinc supplementation as all RCTs included in this 
Bangladesh 2009
Chile 2001
Ghana 2009
Indonesia 2004
India 1993
Iran 2009
Nepal 2003
Pakistan 2004
Peru 2004
Peru 1999
UK 1991b
UK 1991a
UK 1989
USA 1984
USA 2003
USA 1985
USA 1995
Fixed effect model
DL’s random effect model
-0.5 0.0
Effect-size
0.5 1.0 1.5
Fig. Forest plot of 17 randomized controlled 
trials on the association between prenatal 
zinc supplementation and birthweight, 1984
-2009
other reason might be related to the bioavailabili-
ty of zinc supplement. As absorption of dietary 
zinc can be inhibited by iron and phytate intake, 
the same might occur to zinc supplement. Hence, 
zinc level adequate to promote birthweight may 
not be achieved after the supplementation of zinc. 
This hypothesis is also supported by the findings 
of Hunt et al. in the USA (40). According to them, 
zinc supplementation among pregnant Hispanic 
women did not alter the mean zinc levels in serum 
or hair and did not increase the serum zinc level 
significantly compared to the pre-supplementation 
level (40).  
As meta-analysis heavily depends upon published 
studies which are more likely to report significant 
results, non-significant studies which end up in the 
desk-drawer instead of the public domain would be 
systematically avoided. However, in this analysis, 
the problem of publication bias would be less sig-
nificant as the focus of the analysis is a contempo-
rary issue of scientific debate by which reporting 
any direction of association would be reasonably 
interesting to researchers and publishers. 
Conclusions 
The study did not witness any association between 
birthweight and zinc supplementation. However, 
the finding is not conclusive as possible confound-
ing factors were not controlled. This does not 
mean that zinc status is not a possible predictor of 
birthweight as zinc supplementation status may 
not perfectly correlate with serum zinc level. The 
bioavailability of supplemental zinc should also be 
investigated.
analysis reported a satisfactory level of compliance. 
One possible reason might be the risk of potential 
confounding bias in observational studies. The 
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